Procaine is a local anesthetic drug of the amino ester group. It is used primarily to reduce the pain of intramuscular injection of penicillin, and it was also used in dentistry. Owing to the ubiquity of the trade name Novocain, in some regions procaine is referred to generically as novocaine. It acts mainly by being a sodium channel blocker.
Procaine was first synthesized in 1905, shortly after amylocaine, and is the oldest man-made local anesthetic still in clinical use for injection. It was created by the German chemist Alfred Einhorn who gave the chemical the trade name Novocaine, from the Latin ''nov-'' (meaning ''new'') and ''-caine'', a common ending for alkaloids used as anesthetics. It was introduced into medical use by surgeon Heinrich Braun. Prior to the discovery of Stovaine and Novocaine, cocaine was the most commonly used local anesthetic. Procaine is used less frequently today since more effective (and hypoallergenic) alternatives such as lidocaine (Xylocaine) exist. Like other local anesthetics (such as mepivacaine, and prilocaine), procaine is a vasodilator, and is often coadministered with epinephrine for the purpose of vasoconstriction. Vasoconstriction helps to reduce bleeding and prevents the drug from reaching systemic circulation in large amounts. Also unlike cocaine, procaine does not have the euphoric and addictive qualities that put it at risk for abuse. Cocaine is also not a vasodilator.
Procaine, an ester anesthetic, is metabolized in the plasma by the enzyme pseudocholinesterase through hydrolysis into para-amino benzoic acid (PABA), which is then excreted by the kidneys into the urine. Allergic reactions to procaine are usually not in response to procaine itself, but to PABA. About 1 in 3000 people have an atypical form of pseudocholinesterase, which does not hydrolyze ester anesthetics such as procaine, resulting in a prolonged period of high levels of the anesthetic in the blood and increased toxicity.
Procaine is the primary ingredient in the controversial preparation Gerovital H3 by Ana Aslan (Romania), which is claimed by its advocates to remedy many effects of aging. The mainstream medical view is that these claims were seriously studied and discredited in the 1960s.
1% Procaine injection has been recommended for the treatment of extravasation complications associated with venipuncture (along with moist heat, ASA, steroids, antibiotics). It has likewise been recommended for treatment of inadvertent intra-arterial injections (10mL of 1% procaine) as it helps relieve pain and vascular spasm.
Procaine is occasionally added as an additive in illicit street drugs such as cocaine. It is also used by professional dominatrices to enhance BDSM play.
Category:Dental equipment Category:Local anesthetics Category:1905 introductions Category:Benzoates Category:Anilines
cs:Prokain de:Procain es:Procaína fr:Procaïne it:Procaina hu:Prokain nl:Novocaïne ja:プロカイン pl:Prokaina pt:Procaína ro:Procaină ru:Прокаин simple:Procaine sv:ProkainThis text is licensed under the Creative Commons CC-BY-SA License. This text was originally published on Wikipedia and was developed by the Wikipedia community.
Ana Aslan (; 1 January 1897, in Brăila – 20 May 1988, in Bucharest) was a Romanian biologist and physician of Armenian origin. She is considered to be a founding figure of gerontology and geriatrics in Romania. In 1952, under the leadership of Prof. Dr. Ana Aslan, the Geriatric Institute in Bucharest was founded. This Institute was the first of its kind in Romania and was recognized by the World Health Organization.
The remainder of this page concerns a product marketed by Aslan. A mild review of biomedical research literature shows no empirical or peer-reviewed evidence in English that this product prevents or postpones any aspect of aging.
The Gerovital H3 concept was introduced for the first time in 1957, in Verona, Italy, on the occasion of the 4th International Gerontology Congress. Many scientists from the USA , Germany , England, Japan, Italy, Austria and Romania have studied and confirmed the effects of the Gerovital H3 treatment suggested by Prof. Dr. Ana Aslan. In the 60’s the Gerovital H3 treatment became viewed by many to be a scientific certitude (which, readers should note, is an oxymoron, though certainly pedantic enough to appear credible to consumers), a high value anti-aging treatment.
Notables such as French President Charles De Gaulle, U.S. President John F. Kennedy, West German Chancellor Konrad Adenauer, Chinese Chairman Mao Zedong, and Vietnamese Chairman Ho Chi Minh traveled to Romania to attempt to benefit from this anti-aging therapy. Other well-known people, including actresses Marlene Dietrich, Lillian Gish, the Gabor sisters, actors Charlie Chaplin and Kirk Douglas, and artist Salvador Dalí followed the same path.. Once discovered by these celebrities, Gerovital itself became famous and is now used in over twenty countries around the world for its claimed anti-aging properties.
Ana Aslan’s research activity received many international distinctions, for example:
The Gerovital H3 was claimed to be a revolutionary medicine and many people are trying nowadays to profit from its name by marketing derivative drugs.
Counter arguments to the positive effects of the drug are often based on the fact that drugs containing procaine, as does the original GH3, are not approved by the FDA.
Besides the Gerovital H3 Medicine, Ana Aslan also developed Anti Aging cosmetics lines. The original recipes for the preparation of the cosmetics are still respected today by Farmec (Romanian Company), which received the rights from Ana Aslan to produce the Gerovital cosmetics.
The Gerovital cosmetics products include several lines for skin care, hair care, eye care etc. Some of the cosmetics lines produced by Farmec from the original Ana Aslan recipes are: Gerovital H3, Gerovital Plant and Aslavital.
The Cosmetics do not have anything to do with the procaine drugs, are made of natural plant extracts, produced to high quality standards and are generally approved. (also by the FDA)
Category:1897 births Category:1988 deaths Category:People from Brăila Category:Romanian Academy Category:Romanian scientists Category:Romanian biologists Category:Romanian physicians Category:Women biologists Category:Romanian inventors Category:Officers Crosses of the Order of Merit of the Federal Republic of Germany
ca:Ana Aslan de:Ana Aslan fr:Ana Aslan pt:Ana Aslan ro:Ana Aslan sl:Ana AslanThis text is licensed under the Creative Commons CC-BY-SA License. This text was originally published on Wikipedia and was developed by the Wikipedia community.
The World News (WN) Network, has created this privacy statement in order to demonstrate our firm commitment to user privacy. The following discloses our information gathering and dissemination practices for wn.com, as well as e-mail newsletters.
We do not collect personally identifiable information about you, except when you provide it to us. For example, if you submit an inquiry to us or sign up for our newsletter, you may be asked to provide certain information such as your contact details (name, e-mail address, mailing address, etc.).
When you submit your personally identifiable information through wn.com, you are giving your consent to the collection, use and disclosure of your personal information as set forth in this Privacy Policy. If you would prefer that we not collect any personally identifiable information from you, please do not provide us with any such information. We will not sell or rent your personally identifiable information to third parties without your consent, except as otherwise disclosed in this Privacy Policy.
Except as otherwise disclosed in this Privacy Policy, we will use the information you provide us only for the purpose of responding to your inquiry or in connection with the service for which you provided such information. We may forward your contact information and inquiry to our affiliates and other divisions of our company that we feel can best address your inquiry or provide you with the requested service. We may also use the information you provide in aggregate form for internal business purposes, such as generating statistics and developing marketing plans. We may share or transfer such non-personally identifiable information with or to our affiliates, licensees, agents and partners.
We may retain other companies and individuals to perform functions on our behalf. Such third parties may be provided with access to personally identifiable information needed to perform their functions, but may not use such information for any other purpose.
In addition, we may disclose any information, including personally identifiable information, we deem necessary, in our sole discretion, to comply with any applicable law, regulation, legal proceeding or governmental request.
We do not want you to receive unwanted e-mail from us. We try to make it easy to opt-out of any service you have asked to receive. If you sign-up to our e-mail newsletters we do not sell, exchange or give your e-mail address to a third party.
E-mail addresses are collected via the wn.com web site. Users have to physically opt-in to receive the wn.com newsletter and a verification e-mail is sent. wn.com is clearly and conspicuously named at the point of
collection.If you no longer wish to receive our newsletter and promotional communications, you may opt-out of receiving them by following the instructions included in each newsletter or communication or by e-mailing us at michaelw(at)wn.com
The security of your personal information is important to us. We follow generally accepted industry standards to protect the personal information submitted to us, both during registration and once we receive it. No method of transmission over the Internet, or method of electronic storage, is 100 percent secure, however. Therefore, though we strive to use commercially acceptable means to protect your personal information, we cannot guarantee its absolute security.
If we decide to change our e-mail practices, we will post those changes to this privacy statement, the homepage, and other places we think appropriate so that you are aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it.
If we make material changes to our e-mail practices, we will notify you here, by e-mail, and by means of a notice on our home page.
The advertising banners and other forms of advertising appearing on this Web site are sometimes delivered to you, on our behalf, by a third party. In the course of serving advertisements to this site, the third party may place or recognize a unique cookie on your browser. For more information on cookies, you can visit www.cookiecentral.com.
As we continue to develop our business, we might sell certain aspects of our entities or assets. In such transactions, user information, including personally identifiable information, generally is one of the transferred business assets, and by submitting your personal information on Wn.com you agree that your data may be transferred to such parties in these circumstances.